Skip to Main Content

Good morning, everyone, and how are you today? A spot of rain, and then some, is dousing the Pharmalot campus, but we are looking past the clouds and pandemic gloom. After all, the glass is always half full, yes? As George Burns used to say, “I look to the future, because that’s where I’m going to spend the rest of my life.” So join us as we hoist a cup of stimulation to celebrate what lies ahead. And dig in to the list of interesting items below, too. Hope you have a splendid day and stay dry …

The moment some parents have been anxiously awaiting for months is almost here: The Covid-19 vaccine made by Pfizer (PFE) and BioNTech (BNTX) for children aged 5 to 11 will likely be authorized for use in the next week, after completing a four-step process that begins today, STAT explains. It is also a moment some parents have been dreading for months. And over the weekend, they made their concerns known to experts on the Food and Drug Administration’s vaccines advisory committee, which meets today to review the evidence on the safety and efficacy of the vaccine for this age group, with an organized email campaign urging the panel not to recommend the shot.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment